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MTTAbstract To explore material basis of in vitro anti-proliferative activity of leukemia cell K562 of
petroleum ether phase of product resulting from Galium aparine L. 60% ethanol extraction, the
experiment adopts column chromatography combined with thin layer preparation, isolates and
purifies petroleum ether, conducts structural identification of obtained single compound and applies
MTT method for viability assay of in vitro anti-proliferative activity of leukemia cell K562. Exper-
imental results show that G. aparine L. petroleum ether contains mainly b-sitosterol, daucosterol
and dibutyl phthalate and other substances. Under experimental conditions, the three could inhibit
the proliferation of leukemia cell K562 with dose-effect and time-effect relationship, of which dibu-
tyl phthalate has strongest activity. Dibutyl phthalate with excellent activity, b-sitosterol with rich
content and moderate effect should be the main contributor to its biological activity.
 2016 Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Galium aparine L. is a common weed in wheat and barleyfields,
also known as Rubia cordifolia, Scutellaria tuberifera, G. apar-
ine, catchweed bedstraw herb. As herbaceous plant of galliumof rubiaceae, it was first recorded in Yunnan Materia as
Chinese herbal medicine. Traditional medicine holds that
G. aparine L. can clear away damp-heat, eliminate stasis,
dissipate detumescence and detoxify, which can be used for
treatment of stranguria with trubid urine, hematuria, traumatic
injury, acute appendicitis, furuncle, otitis media, etc. In modern
clinical medicine, it is also used for treatment of cancer,
especially leukemia (Yang and Yang, 1975). Among these
traditional Chinese medicine prescription and Chinese medicinal
formulae for treatment of tumors, G. aparine L. serves as
principal drug, which indicates that it has ingredients to
eliminate evil and can suppress tumor cells. However, its
material basis for antitumor activity has not been mentioned
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1994; Health Center in Sandian District, 1972; Chen, 2002;
Peng et al., 2015; Wang, 2005; Zhao and Zhao, 2006; Li and
Chen, 2004; Ling, 2009; Bojko, 1995; Kirillov et al., 2002).
We once adopted ethanol of different concentrations to
extract catchweed bedstraw herb. Activity tracking results
show that petroleum ether phase of material extracted by
60% ethanol can well inhibit leukemia cell viability. In this
paper, column chromatography combined with thin layer
preparation and recrystallization method is adopted to separate
monomer compound, and in vitro anti-proliferative activity of
leukemia cell K562 detection of the resultant monomer com-
pound is done in order to find antitumor activity substances
and lay a foundation for further development and utilization.
2. Experimental method
2.1. Materials, equipment and reagents
G. aparine L. whole plant which was collected from Maoz-
huang, Zhengzhou, in May 2009, and identified by Associate
Professor Yang Huaixia of Henan University of Traditional
Chinese Medicine as herb G. aparine L. of G. aparine of
rubiaceae.
Flash EA1112 element analyzer from US Thermo Electron
SPA company; Nexus470 intelligent Fourier transform infra-
red spectrometer from US Nicolet company; Avance-300
superconducting NMR spectrometer, Avance-400 supercon-
ducting NMR spectrometer, from Germany Bruker; Agilent
1100 LC-MSD-Trap-XCT, from US Agilent company; carbon
dioxide incubator from Shanghai Yiheng company; clean bench
from Suzhou purification equipment plant; BIO-RAD680
microplate reader from US Bio-Rad company; micro-injector
fromGermany eppendorf company; high-speed centrifuge from
US sigma company; culture plate from US costar company.
MTT from US merck; RPMI1640 medium from Gibco
Company; fetal bovine serum from Chinese Academy of Med-
ical Sciences; other reagents are domestic analytical pure.
2.2. Methods
2.2.1. Extraction
Weigh 200 g dried crushed G. aparine L. whole plant, conduct
2 h reflux extraction of 1000 mL of 60% ethanol, extract twice,
filtrate with vacuum concentration and obtain extract, 3 kg
materials are used and 624.5 g extract is obtained.
2.2.2. Extraction
Disperse extract with appropriate amount of distilled water,
extract with petroleum ether, conduct vacuum concentration,
evaporate petroleum ether and obtain 20.8 g petroleum ether
phase.
2.2.3. Preparation
For obtained petroleum ether phase, use petroleum ether: ethyl
acetate as eluent for column chromatography, conduct gradi-
ent elution, test sample with thin layer analysis board, conduct
color detection with UV fluorescence combined with sulfuric
acid – methanol and acetic anhydride – concentrated sulfuric
acid (Liebermann–Burchard reaction); for eluted components,use petroleum ether: ethyl acetate, petroleum ether: chloro-
form and chloroform: methanol as the developing solvents,
repeatedly prepared with silica gel GF254 preparative thin
layer, 3 single compounds are obtained, with concrete results
shown in Table 1.
2.2.4. Anticancer activity assay (MTT method)
Formulate different monomer compounds into DMSO solu-
tion with concentration at 0.1 mol/L, draw 10 lL and dilute
with medium to 1 mL and obtain liquid to be measured. Take
K562 cells of logarithmic growth phase to be inoculated in
three 96-well plates with density at 1  105/cm2, each well with
100 lL. Add 4, 8, 12, 16, and 20 lL soup into each well of sam-
ple set, and supplement volume to 200 lL with medium. Blank
group (only added with culture solution) and control group
(without drug) are set, with six parallel for each group. After
cultured for 48 h, 36 h and 72 h, add MTT, culture for 4 h,
centrifuge, discard supernatant, and add 150 lL DMSO to
each well to fully dissolve the crystals. Measure absorbance
at 570 nm wavelength with microplate reader (Bio-Rad 3350
microplate reader). With blank zero, perform parallel experi-
ments twice and take average value. Calculate cell viability
with the following formula:
cell viability ¼ ðabsorbance of experimental group
=absorbance of control groupÞ  100%:
3. Results and analysis
3.1. Structural analysis of compound
3.1.1. Compound I (b-sitosterol)
As white powder solid, it is positive in sulfuric acid – methanol
and acetic anhydride – concentrated sulfuric acid reaction, and
negative in Molish reaction, which indicates that the com-
pound is a steroid or triterpenoids aglycone; ESI-MS shows
molecular ion peak m/Z: 413 [MH], elemental analysis result:
C element content is 83.92%, H elemental content is 12.06%.
Combined with NMR data, compound formula is speculated
as C29H50O. Calculation obtains that degree of unsaturation
is 5, which indicates that there may be double bond and ring
in compound structure. In infrared IR (cm1) spectrum:
stretching vibration absorption peak at 3425 cm1 shows the
presence of hydroxyl, methyl signal at 2960 cm1 and
2866 cm1, and methylene signal at 2935 cm1 and
2851 cm1; absorption peak relatively weak at 1641 confirms
the presence of double bond.
Nuclear magnetic resonance hydrogen spectrum data indi-
cate the presence of continuous peak envelope at d2.27–1.03,
which may be because of steroid nucleus backbone and side-
chain hydrogen information generated due to overlap of
numerous methylene and sub-methylene signal on steroid
skeleton. d5.34 and d3.51 prove the existence of a unsaturated
CH and hydrogen on one carbon monoxide; nuclear magnetic
resonance spectroscopy only shows two C chemical shift infor-
mation in unsaturated carbon atom region (except alkyne car-
bon atoms): 140.7 ppm, 121.7 ppm, which should be ene
carbon signal; C NMR data show a total of 29 carbon in
compounds. According to dept, it can be seen that there are
a total of 6-methyl, 3 quaternary carbon, 11 methylene, 9
methine.
Table 1 Compound contained in petroleum ether phase of Galium aparine L.




Other Compound III Dibutyl phthalate
Galium aparine L. petroleum ether phase 243Specific NMR data are as follows:
1H NMR (300 MHz, CDCl3) d: 5.34 (1H, t, J= 5.2 Hz,
H-6), 3.51 (1H, m, H-3), 0.68 (3H, s, CH3-18). 13C NMR
(75 MHz, CDCl3) d: 140.7 (C-5), 121.7 (C-6), 71.8 (C-3),
56.8 (C-14), 56.1 (C-17), 50.2 (C-9), 45.8 (C-24), 42.3 (C-13),
42.2 (C-4), 39.8 (C-12), 37.3 (C-1), 36.5 (C-10), 36.2 (C-20),
33.9 (C-22), 31.9 (C-7), 31.9 (C-8), 31.6 (C-2), 29.1 (C-25),
28.3 (C-16), 26.1 (C-23), 24.3 (C-15), 23.1(C-28), 21.1 (C-11),
19.5 (C-19), 19.4 (C-26), 19.1 (C-27), 18.9 (C-21), 12.0 (C-
29), 11.8 (C-18). After consulting the literature, it is found that
the aforesaid data are basically consistent with b-sitosterol
data reported in the literature (Ewa et al., 2013). Therefore,
compound I is identified as b-sitosterol.
3.1.2. Compound II (daucosterol)
As white powder solid, it is positive in Molish reaction and
shown fuchsia after heated in 10% sulfuric acid – methanol
solution. ESI-MS shows molecular ion peak m/Z: 575
[MH], elemental analyzer test results: C element content is
72.83%, H element content is 10.39%. Combined with NMR
data, it is speculated that the compound formula is
C35H60O6. Calculation obtains that degree of unsaturation is
6, which indicates that the compound structure may contain
double bond and ring. In infrared IR (cm1) spectrum: stretch-
ing vibration absorption peak at 3416 cm1 shows the presence
of hydroxyl, methyl signal at 2958 cm1 and 2869 cm1,
methylene signal at 2933 cm1; relatively weak absorption
peak at 1627 cm1 confirms the presence of double bond.
1255 cm1 represents characteristic absorption peak of C–O
stretching vibration in ether bond, while 1075 cm1,
1025 cm1 serve as acetal characteristic signal of pyranose.
Nuclear magnetic resonance hydrogen spectrum shows
d4.11–2.14 continuous peak envelope, which may be numerous
methyl, methylene and sub-methylene signals on steroid skele-
ton and side chain. Nuclear magnetic resonance spectroscopy
shows 35 carbon signals, with three C chemical shift informa-
tion for unsaturated carbon atom region (except alkyne carbon
atoms): 142.2 ppm, 123.2 ppm and 103.6 ppm, of which142.2 ppm, 123.2 ppm should be ene carbon signal,
103.6 ppm should be sugar anomeric carbon signal; 63.9–79.5
are sugar oxygen containing substituted aliphatic carbon
signal. Except sugar carbon signal, signal of nuclear magnetic
resonance spectroscopy of compound II is very close to that of
compound I.
Specific NMR data are as follows:
13C NMR (100 MHz, Pyr-d5) d: 142.2 (C-5), 123.2(C-6),
103.6 (C-10), 79.6 (C-3), 79.5(C-30), 79.4 (C-50), 76.3 (C-20),
72.8 (C-40), 63.9 (C-60), 58.1 (C-14), 57.5 (C-17), 51.6 (C-9),
47.3 (C-24), 43.8 (C-13), 40.5 (C-12), 38.8 (C-4), 38.2 (C-1),
37.6 (C-10), 35.5 (C-20), 33.4 (C-22), 33.3 (C-7), 31.4 (C-8),
31.3 (C-2), 30.7 (C-25), 29.8 (C-16), 27.6 (C-23), 25.8 (C-15),
24.6 (C-28), 22.5 (C-11), 21.3 (C-27), 20.8 (C-19), 20.5(C-26),
20.3 (C-21), 13.2(C-29), 13.2(C-18). After consulting the liter-
ature, it is found that the aforesaid data are basically consis-
tent with daucosterol data reported in the literature
(Mohammad and Mahdi, 2014). Therefore, compound II is
identified as daucosterol.
3.1.3. Compound III (dibutyl phthalate)
In light yellow oil, it shows molecular ion peak m/Z in ESI-
MS: 279 [M+H]+, 301 [M+Na]+, elemental analyzer test
results: C element content is 68.96%, H element content is
7.89%, and thus the compound formula is C16H22O4. Calcula-
tion obtains that degree of unsaturation is 6, which indicates
that the compound structure may contain benzene and two
double bonds or ring. In infrared IR (cm1) spectrum: 2960
and 2874 cm1 are methyl signal, 2934 cm1 is methylene sig-
nal; 1728 cm1 is carbonyl absorption, 1600, 1580, and
1466 cm1 are benzene ring skeleton vibration.
Nuclear magnetic resonance hydrogen spectrum d0.91
shows two methyl of symmetric structure, d1.44, d1.72 show
four symmetrical methylene, d4.31 shows two symmetrical
oxygen methylene; C NMR at 132.3 ppm, 130.9 ppm,
128.8 ppm show aromatic carbon information, 167.7 ppm
shows the presence of carboxylic acid. Specific NMR data
are as follows:
Figure 1 Cytotoxicity of dibutyl phthalate, b-sitosterol and daucosterol on K562 cells (K562 cells were treated with dibutyl phthalate,
b-sitosterol and daucosterol at various concentrations for 24 h (A), 48 h (B), 72 h (C) and cell viability was determined by MTT assay.
Data were shown as mean ± SD (n= 6). #p< 0.05, ##p< 0.01 compared with the control).
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3.5 Hz, H-3, H-6), 7.53 (1H, dd, J= 3.3, 3.3 Hz, H-4, H-5),
4.31 (4H, t, J= 6.3 Hz, H-8, H-80), 1.72 (4H, m, J= 6.3 Hz,
H-9, H-90), 1.44 (4H, m, J= 6.8 Hz, H-10, H-100), 0.91 (6H,
t, J= 7.3 Hz, H-11, H-110); 13C NMR (75 MHz, CDCl3) d:
167.7 (C-7, 70), 132.3 (C-1, 2), 130.9 (C-4, 5), 128.8 (C-3, 6),
65.5 (C-8, 80), 30.6 (C-9, 90), 19.2 (C-10, 100), 13.7 (C-11,
110). After consulting the literature, it is found that the afore-
said spectral data are basically consistent with dibutyl phtha-
late data reported in the literature (Zhang et al., 2006).
Therefore, the compound is identified as dibutyl phthalate.
3.2. Assay of in vitro anti-proliferative activity of leukemia cell
K562
By column chromatography combined with thin layer prepara-
tion, isolate and identify three single compounds from petro-
leum ether phase extracted from 20.8 g catchweed bedstraw
herb with 60% ethanol: 6.3 g b-sitosterol, 281 mg daucosterol
and 962 mg phthalate butyl. Test results of in vitro anti-
proliferative activity of K562 cell are shown in Fig. 1.
As can be seen from Fig. 1, under condition of experimental
concentration, the three can inhibit the proliferation of leuke-
mia cell K562, wherein b-sitosterol and daucosterol have mod-
erate inhibition effect, while dibutyl phthalate has very obvious
effect. Their inhibition ability shows dose-effect and time-
effect relationship. That is, with increase in dose and extension
of dosing time, inhibition effect gets stronger.
4. Conclusion
Three single compounds were separated from 60% ethanol
petroleum ether phase of G. aparine L., respectively
b-sitosterol, daucosterol and dibutyl phthalate. Dibutyl phtha-
late has been found in many plants. For instance, Zhang Don-
ghui obtained such substance from Stellera chamaejasme, Diao
Mingyuan from evodia lepta of rutaceous plant, Li Xiaobao
from roots of Polyalthia laui in Hainan. Studies by Chu-tse
Wu et al. have shown that this compound can significantly kill
leukemia cells in vivo and in vitro selectively, and its mecha-
nism may be related to dibutyl phthalate characteristic that
it can affect expression of some oncogenes and tumor suppres-
sor genes and thus induce tumor cell apoptosis (Wu et al.,
1993). Our experimental results also show that dibutylphthalate has excellent in vitro anti-proliferative activity of
leukemia cell K562.
Dibutyl phthalate with excellent activity and b-sitosterol
with rich contents and moderate anti-tumor activity should
be material basis for catchweed bedstraw herb with 60% etha-
nol to extract biological activity from petroleum ether phase.
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